目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Herpes Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Vaccination - Market size and forecast 2023-2028
Chart on Vaccination - Market size and forecast 2023-2028 ($ million)
Data Table on Vaccination - Market size and forecast 2023-2028 ($ million)
Chart on Vaccination - Year-over-year growth 2023-2028 (%)
Data Table on Vaccination - Year-over-year growth 2023-2028 (%)
6.4 Drug therapy - Market size and forecast 2023-2028
Chart on Drug therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million)
Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Herpes zoster - Market size and forecast 2023-2028
Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million)
Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million)
Chart on Herpes zoster - Year-over-year growth 2023-2028 (%)
Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%)
7.4 Herpes simplex - Market size and forecast 2023-2028
Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million)
Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million)
Chart on Herpes simplex - Year-over-year growth 2023-2028 (%)
Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 AiCuris Anti infective Cures AG
AiCuris Anti infective Cures AG - Overview
AiCuris Anti infective Cures AG - Product / Service
AiCuris Anti infective Cures AG - Key offerings
12.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.6 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
12.9 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key offerings
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Maruho Co. Ltd.
Maruho Co. Ltd. - Overview
Maruho Co. Ltd. - Product / Service
Maruho Co. Ltd. - Key news
Maruho Co. Ltd. - Key offerings
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12.17 Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. - Overview
Zydus Lifesciences Ltd. - Business segments
Zydus Lifesciences Ltd. - Key news
Zydus Lifesciences Ltd. - Key offerings
Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Vaccination - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Vaccination - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Vaccination - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Vaccination - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Drug therapy - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Data Table on Market opportunity by Product ($ million)
Exhibits46: Chart on Type - Market share 2023-2028 (%)
Exhibits47: Data Table on Type - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Type
Exhibits49: Data Table on Comparison by Type
Exhibits50: Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Herpes zoster - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Herpes simplex - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Type ($ million)
Exhibits59: Data Table on Market opportunity by Type ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: AbbVie Inc. - Overview
Exhibits110: AbbVie Inc. - Product / Service
Exhibits111: AbbVie Inc. - Key news
Exhibits112: AbbVie Inc. - Key offerings
Exhibits113: AiCuris Anti infective Cures AG - Overview
Exhibits114: AiCuris Anti infective Cures AG - Product / Service
Exhibits115: AiCuris Anti infective Cures AG - Key offerings
Exhibits116: Aurobindo Pharma Ltd. - Overview
Exhibits117: Aurobindo Pharma Ltd. - Product / Service
Exhibits118: Aurobindo Pharma Ltd. - Key offerings
Exhibits119: Cipla Inc. - Overview
Exhibits120: Cipla Inc. - Business segments
Exhibits121: Cipla Inc. - Key offerings
Exhibits122: Cipla Inc. - Segment focus
Exhibits123: Eli Lilly and Co. - Overview
Exhibits124: Eli Lilly and Co. - Product / Service
Exhibits125: Eli Lilly and Co. - Key news
Exhibits126: Eli Lilly and Co. - Key offerings
Exhibits127: Fresenius SE and Co. KGaA - Overview
Exhibits128: Fresenius SE and Co. KGaA - Business segments
Exhibits129: Fresenius SE and Co. KGaA - Key news
Exhibits130: Fresenius SE and Co. KGaA - Key offerings
Exhibits131: Fresenius SE and Co. KGaA - Segment focus
Exhibits132: Gilead Sciences Inc. - Overview
Exhibits133: Gilead Sciences Inc. - Product / Service
Exhibits134: Gilead Sciences Inc. - Key offerings
Exhibits135: GlaxoSmithKline Plc - Overview
Exhibits136: GlaxoSmithKline Plc - Business segments
Exhibits137: GlaxoSmithKline Plc - Key news
Exhibits138: GlaxoSmithKline Plc - Key offerings
Exhibits139: GlaxoSmithKline Plc - Segment focus
Exhibits140: Maruho Co. Ltd. - Overview
Exhibits141: Maruho Co. Ltd. - Product / Service
Exhibits142: Maruho Co. Ltd. - Key news
Exhibits143: Maruho Co. Ltd. - Key offerings
Exhibits144: Merck and Co. Inc. - Overview
Exhibits145: Merck and Co. Inc. - Business segments
Exhibits146: Merck and Co. Inc. - Key news
Exhibits147: Merck and Co. Inc. - Key offerings
Exhibits148: Merck and Co. Inc. - Segment focus
Exhibits149: Novartis AG - Overview
Exhibits150: Novartis AG - Business segments
Exhibits151: Novartis AG - Key news
Exhibits152: Novartis AG - Key offerings
Exhibits153: Novartis AG - Segment focus
Exhibits154: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits155: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits156: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits157: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits163: Viatris Inc. - Overview
Exhibits164: Viatris Inc. - Business segments
Exhibits165: Viatris Inc. - Key news
Exhibits166: Viatris Inc. - Key offerings
Exhibits167: Viatris Inc. - Segment focus
Exhibits168: Zydus Lifesciences Ltd. - Overview
Exhibits169: Zydus Lifesciences Ltd. - Business segments
Exhibits170: Zydus Lifesciences Ltd. - Key news
Exhibits171: Zydus Lifesciences Ltd. - Key offerings
Exhibits172: Zydus Lifesciences Ltd. - Segment focus
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Information sources
Exhibits178: Data validation
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Data synthesis
Exhibits181: 360 degree market analysis
Exhibits182: List of abbreviations